Female Health Co(NASDAQ:FHCO) announced the earnings results for Fiscal Year 2016 and Q3. The results came in during Pre-market on Jul 28, 2016. Earnings per share were $0.02.
Female Health Co (FHCO) made into the market gainers list on Thursdays trading session with the shares advancing 7.71% or 0.1041 points. Due to strong positive momentum, the stock ended at $1.4541, which is also near the day’s high of $1.65. The stock began the session at $1.6 and the volume stood at 11,97,796 shares. The 52-week high of the shares is $2.75 and the 52 week low is $1.16. The company has a current market capitalization of $42 M and it has 2,90,52,667 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jun 15, 2016, Andrew S Jr Love (director) purchased 23,790 shares at $1.43 per share price.Also, On May 26, 2016, Michele Greco (CFO) purchased 4,000 shares at $1.28 per share price.On May 25, 2016, O B Parrish (CEO) purchased 10,000 shares at $1.29 per share price, according to the Form-4 filing with the securities and exchange commission.
The Female Health Company is a Female Condom company. The Company is engaged in manufacturing marketing and selling FC2 Female Condom (FC2). FC2 is used for both disease prevention and family planning the public health sector is the Companys market. The Company operates in one industry segment which includes the development manufacture and marketing of consumer health care products. The FC2 product offered by the Company facilitates dual protection for women against both unintended pregnancy and STIs including HIV and AIDS its market encompasses both family planning and disease prevention. FC2s primary usages are for disease prevention and family planning the public health sector is the Companys main market. The Company markets products that prevent the transmission of HIV and AIDS through sexual intercourse: the male condom and FC2.